Lymphoma is a cancer of the lymphatic system — an essential network of vessels, lymph nodes, spleen, bone marrow, and immune cells that protects the body against infections. When lymphocytes (a type of white blood cell) undergo malignant transformation, they multiply uncontrollably and form tumors within lymph nodes or other organs.
Unlike many solid tumors, lymphoma may not begin as a visible mass in a single organ. Instead, it often presents as painless swelling of lymph nodes, unexplained fever, weight loss, night sweats, or fatigue. Because symptoms can be subtle in the early stages, timely medical evaluation is critical.
Modern treatment has dramatically improved survival in both early and advanced lymphoma. However, successful treatment begins with accurate diagnosis, correct subtyping, and proper staging. Surgical oncology plays a vital role in this process — particularly in obtaining adequate tissue for diagnosis and managing complications when they arise.
Dr. Lovedeep Singh Chauhan, Consultant Surgical Oncologist at Max Super Speciality Hospital, Mohali, provides comprehensive lymphoma-related surgical care including excisional lymph node biopsy, minimally invasive diagnostic procedures, and coordinated multidisciplinary management.
The lymphatic system functions as part of the immune defense mechanism. It transports lymph fluid containing lymphocytes throughout the body. Lymph nodes act as filters, trapping infections and abnormal cells.
Lymphoma develops when these lymphocytes — either B cells or T cells — become cancerous. These abnormal cells accumulate in lymph nodes or organs and lose their ability to regulate growth.
Lymphoma is broadly divided into two major categories:
Hodgkin lymphoma (HL) is identified by the presence of Reed–Sternberg cells on microscopic examination. It most commonly affects adolescents and young adults, though it can occur at any age.
Clinically, patients often present with painless enlargement of lymph nodes in the neck, chest, or armpit. One distinguishing feature of Hodgkin lymphoma is its predictable pattern of spread — typically moving from one group of lymph nodes to adjacent ones.
With modern chemotherapy and radiation protocols, Hodgkin lymphoma has one of the highest cure rates among cancers, particularly when diagnosed at an early stage.
Non-Hodgkin lymphoma (NHL) represents a diverse group of lymphoid malignancies. It is more common than Hodgkin lymphoma and includes both indolent (slow-growing) and aggressive forms.
Unlike Hodgkin lymphoma, NHL may arise not only in lymph nodes but also in extranodal sites such as the stomach, intestine, thyroid, skin, or brain. The disease behavior varies widely — some subtypes progress slowly over years, while others require urgent treatment due to rapid growth.
Precise pathological classification is essential, as treatment differs significantly between subtypes.
Lymphoma symptoms can overlap with common infections, which sometimes delays diagnosis. However, certain warning signs warrant further evaluation:
These symptoms, particularly when occurring together (known as “B symptoms”), may indicate systemic disease and should not be ignored.
Warning signs that may require medical evaluation:
These symptoms, particularly when occurring together (known as “B symptoms”), may indicate systemic disease and should not be ignored.
The exact cause of lymphoma remains uncertain. However, several risk factors are associated with increased susceptibility:
Importantly, many individuals diagnosed with lymphoma have no identifiable risk factors.
One of the most important steps in lymphoma management is obtaining sufficient tissue for pathological examination. Unlike many cancers where imaging may suggest diagnosis, lymphoma requires microscopic and molecular confirmation before treatment begins.
An excisional biopsy involves complete removal of an affected lymph node. This allows the pathologist to evaluate:
Fine needle aspiration (FNAC) often fails to provide adequate architectural detail and may lead to inconclusive results. For this reason, excisional biopsy is preferred whenever feasible.
Deep-seated lymph nodes (such as mediastinal or abdominal nodes) may require image-guided or minimally invasive surgical approaches to obtain diagnostic tissue safely.
Once lymphoma is confirmed, staging helps determine how far the disease has spread. Modern staging typically includes PET-CT scanning, blood tests, and sometimes bone marrow biopsy.
Lymphoma staging is classified as:
Accurate staging directly influences treatment intensity and prognosis.
Unlike most solid tumors, lymphoma is primarily treated with systemic therapy rather than surgery.
Managing complications like abdominal pain, bleeding, anemia, or obstruction. Minimally invasive techniques allow for faster recovery.
Collaborative decision-making via Tumor Boards.
Dr. Lovedeep Singh Chauhan is an MCh-trained Surgical Oncologist with experience in advanced oncologic procedures. At Max Super Speciality Hospital, Mohali, he provides comprehensive surgical support for lymphoma patients.
His approach emphasizes:
Small gastric GISTs often have excellent outcomes, while large small-intestinal GISTs with high mitotic rates carry a higher risk of recurrence. This risk classification guides decisions regarding adjuvant therapy.
During consultation, patients receive:
The objective is not merely to perform a procedure, but to ensure the correct pathway to effective treatment.
Prognosis varies based on subtype and stage. Hodgkin lymphoma has excellent cure rates, especially in early stages.
Many aggressive Non-Hodgkin lymphomas are also highly treatable with modern chemotherapy and immunotherapy.
Early diagnosis and appropriate staging significantly improve outcomes and reduce treatment-related complications.